Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Blockade of tolerance to morphine analgesia by cocaine.

Misra AL, Pontani RB, Vadlamani NL.

Pain. 1989 Jul;38(1):77-84.

PMID:
2780065
2.

Interactions of cocaine with barbital, pentobarbital and ethanol.

Misra AL, Pontani RB, Vadlamani NL.

Arch Int Pharmacodyn Ther. 1989 May-Jun;299:44-54.

PMID:
2774771
3.

Intravenous kinetics and metabolism of [15,16-3H]naltrexonium methiodide in the rat.

Misra AL, Pontani RB, Vadlamani NL.

J Pharm Pharmacol. 1987 Mar;39(3):225-7.

PMID:
2883290
4.

Stereospecific potentiation of opiate analgesia by cocaine: predominant role of noradrenaline.

Misra AL, Pontani RB, Vadlamani NL.

Pain. 1987 Jan;28(1):129-38.

PMID:
3822492
5.

Effect of caffeine on cocaine locomotor stimulant activity in rats.

Misra AL, Vadlamani NL, Pontani RB.

Pharmacol Biochem Behav. 1986 Mar;24(3):761-4.

PMID:
3703910
6.

Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant.

Pontani RB, Vadlamani NL, Misra AL.

Xenobiotica. 1985 Apr;15(4):287-97.

PMID:
4024663
7.

Potentiation of morphine analgesia by caffeine.

Misra AL, Pontani RB, Vadlamani NL.

Br J Pharmacol. 1985 Apr;84(4):789-91.

8.

Potentiation of morphine analgesia by subanesthetic doses of pentobarbital.

Pontani RB, Vadlamani NL, Misra AL.

Pharmacol Biochem Behav. 1985 Mar;22(3):395-8.

PMID:
3991755
9.

Effect of diamorphine, delta 9-tetrahydrocannabinol and ethanol on intravenous cocaine disposition.

Vadlamani NL, Pontani RB, Misra AL.

J Pharm Pharmacol. 1984 Aug;36(8):552-4.

PMID:
6148403
10.

Increased brain uptake of morphine in the presence of the antihistamine tripelennamine.

Vadlamani NL, Pontani RB, Misra AL.

J Pharm Pharmacol. 1984 Jan;36(1):61-3.

PMID:
6141270
11.

Effect of chronic nicotine pre-treatment on phencyclidine (PCP) disposition in the rat.

Vadlamani NL, Pontani RB, Misra AL.

Arch Int Pharmacodyn Ther. 1983 Sep;265(1):4-12.

PMID:
6651404
12.

A long-acting buprenorphine delivery system.

Pontani RB, Misra AL.

Pharmacol Biochem Behav. 1983 Mar;18(3):471-4.

PMID:
6836002
13.

Effect of acute and chronic ethanol pre-treatment on the disposition of phencyclidine (PCP) in the rat.

Vadlamani NL, Pontani RB, Misra AL.

Pharmacol Biochem Behav. 1982 May;16(5):847-50.

PMID:
7089042
14.

An improved long-acting delivery system for narcotic antagonists.

Misra AL, Pontani RB.

NIDA Res Monogr. 1981;28:254-64.

PMID:
6791009
15.

Current status of preclinical research on disposition, pharmacokinetics, and metabolism of naltrexone.

Misra AL.

NIDA Res Monogr. 1981;28:132-46. Review. No abstract available.

PMID:
6267469
16.

Disposition of [3H] phencyclidine in the rat after single and multiple doses.

Misra AL, Pontani RB, Bartolomeo JG.

Life Sci. 1980 Dec 22-29;27(25-26):2501-8. No abstract available.

PMID:
7219023
17.

Pharmacokinetics and metabolism of l-alpha-[O,O'-3H2]-acetyl normethadol (nor-LAAM), the active metabolite of LAAM, in acutely and chronically treated rhesus monkeys.

Misra AL, Bartolomeo JG, Bloch R, Mulé SJ, Bates TR.

J Pharmacol Exp Ther. 1980 Sep;214(3):599-607. No abstract available.

PMID:
6772759
18.

Effect of cortisone-pretreatment of rats on the disposition of a narcotic antagonist.

Misra AL, Vadlamani NL, Pontani RB.

Res Commun Chem Pathol Pharmacol. 1979 Jul;25(1):169-72. No abstract available.

PMID:
451351
19.

Persistence of phencyclidine (PCP) and metabolites in brain and adipose tissue and implications for long-lasting behavioural effects.

Misra AL, Pontani RB, Bartolomeo J.

Res Commun Chem Pathol Pharmacol. 1979 Jun;24(3):431-45.

PMID:
451333
20.

Metabolism of norcocaine, N-hydroxy norcocaine and cocaine-N-oxide in the rat.

Misra AL, Pontani RB, Vadlamani NL.

Xenobiotica. 1979 Mar;9(3):189-99.

PMID:
473794
21.

Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys.

Misra AL, Mulé SJ, Bloch R, Bates TR.

J Pharmacol Exp Ther. 1978 Aug;206(2):475-91. No abstract available.

PMID:
98628
22.
23.

An improved long-acting delivery system for narcotic antagonists.

Misra AL, Pontani RB.

J Pharm Pharmacol. 1978 May;30(5):325-6. No abstract available.

PMID:
26754
24.

Comparative effects of cocaine and pseudococaine on EEG activities, cardiorespiratory functions, and self-administration behavior in the rhesus monkey.

Matsuzaki M, Spingler PJ, Whitlock EG, Misra AL, Mulé SJ.

Psychopharmacology (Berl). 1978 Apr 14;57(1):13-20.

PMID:
96463
25.

Plasma corticosteroid levels in rats maintained on a long-acting naltrexone delivery system.

Misra AL, Pontani RB, Vadlamani NL.

Res Commun Chem Pathol Pharmacol. 1978 Apr;20(1):43-50.

PMID:
663407
26.

Clearance and analgesic activity of the quaternized opiate, N-methylmorphine [6-3H] administered intracisternally to the rat.

Misra AL, Vadlamani NL, Pontani RB.

J Pharm Pharmacol. 1978 Mar;30(3):187-8. No abstract available.

PMID:
24696
27.

Pharmacology of l-alpha-acetylmethadol (LAAM) in subhuman primates.

Mulé SJ, Misra AL.

Ann N Y Acad Sci. 1978;311:199-213. No abstract available.

PMID:
105659
28.

Evidence for a noncovalent intermolecular interaction of opiates with thiamine.

Misra AL, Vadlamani NL, Pontani RB.

Res Commun Chem Pathol Pharmacol. 1977 Nov;18(3):581-4.

PMID:
928957
29.

Comparison of the convulsant effects of cocaine and pseudococaine in the rhesus monkey.

Matsuzaki M, Misra AL.

Brain Res Bull. 1977 Nov-Dec;2(6):417-24.

PMID:
414826
30.

Disposition and metabolism of psi-cocaine (dextrococaine) in the rat.

Misra AL, Pontani RB.

Drug Metab Dispos. 1977 Nov-Dec;5(6):556-63. No abstract available.

PMID:
21779
31.

Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys.

Misra AL, Giri VV, Patel MN, Alluri VR, Mulé SJ.

Drug Alcohol Depend. 1977 Jul;2(4):261-72. No abstract available.

PMID:
560292
32.

Differential effects of opiates on the incorporation of [14C] thiamine in the central nervous system of the rat.

Misra AL, Vadlamani NL, Pontani RB.

Experientia. 1977 Mar 15;33(3):372-4.

PMID:
858372
33.
34.

Intracellular disposition of (3H)-cocaine, (3H)-norcocaine, (3H)-benzoylecgonine and (3H)-benzoylnorecgonine in the brain of rats.

Mule SJ, Casella GA, Misra AL.

Life Sci. 1976 Nov 15;19(10):1585-96. No abstract available.

PMID:
994703
35.

Molecular complexes of cocaine, its active metabolites and some other stimulants with thiamine.

Misra AL, Vadlamani NL.

Res Commun Chem Pathol Pharmacol. 1976 Oct;15(2):401-4.

PMID:
10608
36.

Disposition and metabolism of [3H]cocaine in acutely and chronically treated dogs.

Misra AL, Patel MN, Alluri VR, Mulé SJ, Nayak PK.

Xenobiotica. 1976 Sep;6(9):537-52.

PMID:
983124
37.

Cocaine: tolerance to its convulsant and cardiorespiratory stimulating effects in the monkey.

Matsuzaki M, Spingler PJ, Misra AL, Mule SJ.

Life Sci. 1976 Jul 15;19(2):193-203. No abstract available.

PMID:
822244
38.

Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.

Misra AL, Bloch R, Vardy J, Mulé SJ, Verebely K.

Drug Metab Dispos. 1976 May-Jun;4(3):276-80.

PMID:
6233
39.

Disposition of (3H) benzoylnorecgonine (cocaine metabolite) in the rat.

Misra AL, Giri VV, Patel MN, Alluri VR, Pontani RB, Mule SJ.

Res Commun Chem Pathol Pharmacol. 1976 Apr;13(4):579-84.

PMID:
1265338
40.

Pharmacokinetics and metabolism of (-)-alpha-[2-3H]acetylmethadol (LAAM) in the monkey: evidence for a new metabolite.

Misra AL, Vardy J, Bloch R, Mulé SJ, Deneau GA.

J Pharm Pharmacol. 1976 Apr;28(4):316-8. No abstract available.

PMID:
6726
41.

Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.

Nayak PK, Misra AL, Mulé SJ.

J Pharmacol Exp Ther. 1976 Mar;196(3):556-69.

PMID:
1263111
42.

Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.

Misra AL, Pontani RB, Vadlamani NL, Mulé SJ.

J Pharmacol Exp Ther. 1976 Feb;196(2):257-68.

PMID:
1255476
44.

Estimation and disposition of [3H]benzoylecgonine and pharmacological activity of some cocaine metabolites.

Misra AL, Nayak PK, Bloch R, Mulé SJ.

J Pharm Pharmacol. 1975 Oct;27(10):784-6. No abstract available.

PMID:
241797
45.

Calcium-binding property of cocaine and some of its active metabolites-formation of molecular complexes.

Misra AL, Mule SJ.

Res Commun Chem Pathol Pharmacol. 1975 Aug;11(4):663-6.

PMID:
1179036
46.

Laeve-[1-3H]Methadone disposition in tolerant dogs.

Misra AL, Bloch R, Vadlamani NL, Mulé SJ.

Xenobiotica. 1975 Apr;5(4):237-44.

PMID:
1154803
47.
48.

1-alpha-acetylmethadol(LAAM) pharmacokinetics and metabolism: current status.

Misra AL, Mulé SJ.

Am J Drug Alcohol Abuse. 1975;2(3-4):301-5. No abstract available.

PMID:
818895
49.

Some physicochemical and pharmacological properties of morphine-2,3-quinone, the morphine metabolite in the rat brain.

Misra AL, Vadlamani NL, Pontani RB, Mulé SJ.

J Pharm Pharmacol. 1974 Dec;26(12):990-2. No abstract available.

PMID:
4142797
50.

Identification of norcocaine as a metabolite of (3H)-cocaine in rat brain.

Misra AL, Nayak PK, Patel MN, Vadlamani NL, Mulé SJ.

Experientia. 1974 Nov 15;30(11):1312-4. No abstract available.

PMID:
4435177

Supplemental Content

Loading ...
Support Center